Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessia Villani

Showing results (11-20 of 140) with videos related to

Pageof 14
Sort By:
Dermatologic Therapy|May 25, 2019
Efficacy and safety of vismodegib in patients with basal cell carcinoma: An Italian Center experienceMassimiliano Scalvenzi, Alessia Villani, Claudia Costa, et al.
Dermatology and Therapy|April 15, 2021
Reflectance Confocal Microscopy Identification of Subclinical Basal Cell Carcinoma after Vismodegib Treatment: Report of a CaseAlessia Villani, Gabriella Fabbrocini, Claudia Costa, et al.
Journal of the American Academy of Dermatology|April 4, 2020
Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatmentAlessia Villani, Gabriella Fabbrocini, Claudia Costa, et al.
Dermatologic Therapy|December 31, 2020
Awareness on sun protection behavior among melanoma and nonmelanoma skin cancer patients: An Italian tertiary cancer center experienceAlessia Villani, Gabriella Fabbrocini, Claudia Costa, et al.
Italian Journal of Dermatology and Venereology|October 31, 2018
The remarkable increase of squamous cell carcinomas: a retrospective single-center study of 14-years study periodClaudia Costa, Massimiliano Scalvenzi, Gabriella Fabbrocini, et al.
Skin Appendage Disorders|October 22, 2020
Hair Loss in Patients Treated with Vismodegib: A Single-Center Retrospective StudyAlessia Villani, Gabriella Fabbrocini, Claudia Costa, et al.
Clinical and Experimental Dermatology|July 7, 2022
Patient satisfaction with remote dermatology consultations during the COVID-19 pandemic. Comment on 'A qualitative assessment of patient satisfaction with remote dermatology consultations used during the UK's first wave of the COVID-19 pandemic in a single, secondary-care dermatology department'Fabrizio Martora, Angelo Ruggiero, Gabriella Fabbrocini, et al.
Dermatologic Therapy|July 19, 2022
Giant basal cell carcinoma of the vulva successfully treated with SonidegibElisa Camela, Alessia Villani, Massimiliano Scalvenzi, et al.
Skin Appendage Disorders|March 1, 2019
It Is Not as It SeemsAlessia Villani, Maria Ferrillo, Gabriella Fabbrocini, et al.
Dermatology and Therapy|May 30, 2020
Melanoma Screening Days During the Coronavirus Disease 2019 (COVID-19) Pandemic: Strategies to AdoptAlessia Villani, Gabriella Fabbrocini, Claudia Costa, et al.
Pageof 14

Showing results (11-20 of 140) with videos related to

Sort By:
Pageof 14
Dermatologic Therapy|May 25, 2019
Efficacy and safety of vismodegib in patients with basal cell carcinoma: An Italian Center experienceMassimiliano Scalvenzi, Alessia Villani, Claudia Costa, et al.
Dermatology and Therapy|April 15, 2021
Reflectance Confocal Microscopy Identification of Subclinical Basal Cell Carcinoma after Vismodegib Treatment: Report of a CaseAlessia Villani, Gabriella Fabbrocini, Claudia Costa, et al.
Journal of the American Academy of Dermatology|April 4, 2020
Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatmentAlessia Villani, Gabriella Fabbrocini, Claudia Costa, et al.
Dermatologic Therapy|December 31, 2020
Awareness on sun protection behavior among melanoma and nonmelanoma skin cancer patients: An Italian tertiary cancer center experienceAlessia Villani, Gabriella Fabbrocini, Claudia Costa, et al.
Italian Journal of Dermatology and Venereology|October 31, 2018
The remarkable increase of squamous cell carcinomas: a retrospective single-center study of 14-years study periodClaudia Costa, Massimiliano Scalvenzi, Gabriella Fabbrocini, et al.
Skin Appendage Disorders|October 22, 2020
Hair Loss in Patients Treated with Vismodegib: A Single-Center Retrospective StudyAlessia Villani, Gabriella Fabbrocini, Claudia Costa, et al.
Clinical and Experimental Dermatology|July 7, 2022
Patient satisfaction with remote dermatology consultations during the COVID-19 pandemic. Comment on 'A qualitative assessment of patient satisfaction with remote dermatology consultations used during the UK's first wave of the COVID-19 pandemic in a single, secondary-care dermatology department'Fabrizio Martora, Angelo Ruggiero, Gabriella Fabbrocini, et al.
Dermatologic Therapy|July 19, 2022
Giant basal cell carcinoma of the vulva successfully treated with SonidegibElisa Camela, Alessia Villani, Massimiliano Scalvenzi, et al.
Skin Appendage Disorders|March 1, 2019
It Is Not as It SeemsAlessia Villani, Maria Ferrillo, Gabriella Fabbrocini, et al.
Dermatology and Therapy|May 30, 2020
Melanoma Screening Days During the Coronavirus Disease 2019 (COVID-19) Pandemic: Strategies to AdoptAlessia Villani, Gabriella Fabbrocini, Claudia Costa, et al.
Pageof 14